Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.

Head & neck - 1 Apr 2016

Luk Peter P, Weston Jared D, Yu Bing, Selinger Christina I, Ekmejian Rafael, Eviston Timothy J, Lum Trina, Gao Kan, Boyer Michael, O'Toole Sandra A, Clark Jonathan R, Gupta Ruta

Abstract excerpt

BACKGROUND: Accurate diagnosis of salivary duct carcinoma requires a high index of suspicion and clinicopathologic correlation. Hallmark genetic changes that may provide novel therapeutic options are being explored. METHODS: One hundred ninety salivary gland malignancies at Royal Prince Alfred Hospital (from 1989-2014) were reviewed. Human epidermal growth factor receptor 2 (HER2) and androgen receptor status...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to GTP Phosphohydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Proto-Oncogene Proteins c-akt

Share to Proto-Oncogene Proteins p21(ras)

Share to Receptor, ErbB-2

Share to Receptors, Androgen

Share to Salivary Gland Neoplasms

Source

Identifiers

PMID: 26699379
DOI: 10.1002/hed.24332

Genes

AKT1
HRAS
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.PMID 26699379Read ↗

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Semantic proximity Read ↗

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profilingSemantic proximity Read ↗

Salivary gland carcinoma: Towards a more personalised approach.Semantic proximity Read ↗

Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Semantic proximity Read ↗

Salivary gland pathologies: evolution in classification and association with unique genetic alterations.Semantic proximity Read ↗

Parotid Salivary Duct Carcinoma With a Prominent Squamous Component: Immunohistochemical Profile, Diagnostic Pitfalls, and Therapeutic Implications.Semantic proximity Read ↗

Salivary gland cancers: current treatments, molecular characteristics and new therapies.Semantic proximity Read ↗

[Salivary gland cancer: new therapeutic approaches].Semantic proximity Read ↗

Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.Semantic proximity Read ↗

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.Semantic proximity Read ↗

Salivary Gland Cancers: Biology and Molecular Targets for TherapySemantic proximity Read ↗

The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.